ChemMedChem
 | |
| Discipline | Chemistry |
|---|---|
| Language | English |
| Edited by | David Peralta |
| Publication details | |
Publication history | 2006 - present |
| Publisher | |
| Frequency | Twice a month |
| 3.225 | |
| Standard abbreviations | |
| ChemMedChem | |
| Indexing | |
| CODEN | CHEMGX |
| ISSN |
1860-7179 (print) 1860-7187 (web) |
| Links | |
ChemMedChem is a monthly peer-reviewed medicinal chemistry journal. It is co-owned by the 14 European chemical society members of ChemPubSoc Europe and is published by Wiley-VCH. Its 2016 impact factor is 3.225.[1][2] In addition to original research in the form of full papers and shorter communications, ChemMedChem contains review-type articles (reviews, minireviews, patent reviews, essays, highlights) as well as occasional book reviews and conference reports. The first volume was published at the beginning of 2006 under the two founding chemical societies, the German Chemical Society (GDCh) and the Italian Chemical Society (SCI). Since then, 12 additional chemical societies have joined in co-ownership of the journal. ChemMedChem is a sister publication to other scientific journals published by Wiley-VCH, including Angewandte Chemie, ChemBioChem, ChemPhysChem, ChemSusChem, ChemCatChem, and ChemistryViews. Topics covered in ChemMedChem include drug design, development and delivery, molecular modeling, combinatorial chemistry, drug target validation, lead generation, ADMET studies, and as of 2017, nanomedicine (including targeted drug delivery, theranostics, and nanodrugs).